17) Whether to give #antibiotics is more controversial. A #Cochrane review says that it’s a no-brainer in severe exacerbations requiring a hospitalization, but in mild exacerbations for outpatients, it's much more uncertain. See 🔓https://t.co/St5zlfqdCU
@jmsirvent3 En las leves, es una opción clara. En ingresados, la evidencia es la que es, no nos lo pone fácil (o sí, según se mire). https://t.co/wzqlq4Hgxl
Howe cited https://t.co/xMnQxd9OLZ
@Rick_Pescatore @Adena_EM_DrMP @c_w_morrison I know the GOLD guidelines well, and for the most part agree but this and a few other articles forwarded to me recently made me ponder. At this point I still feel benefit > risk but it’s something to consider
Antibiotics for exacerbations of COPD. Cochrane Database Syst Rev. 2018 Oct 29;10:CD010257. https://t.co/enEczMcVHF
RT @benjaminwumd: @gretchemaben https://t.co/zxniygKgn8 Sorry I linked the wrong article, here is the review.
@gretchemaben https://t.co/zxniygKgn8 Sorry I linked the wrong article, here is the review.
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @ladenheimd: More from @cochranecollab. A recent audit of GP practices @ENHertsCCG showed many pts in this cohort are on 12 or more acut…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @anne_h_thom: Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow t…
RT @ryoma_tanaka: COPD急性増悪に抗菌薬は有効か?というコクランレビュー。 ICU患者では明らかに有効という結果。この条件に合うRCTは1つしかないので、その1つの結果からなのですが。 https://t.co/xlM0T3ImcT
RT @ryoma_tanaka: COPD急性増悪に抗菌薬は有効か?というコクランレビュー。 ICU患者では明らかに有効という結果。この条件に合うRCTは1つしかないので、その1つの結果からなのですが。 https://t.co/xlM0T3ImcT
RT @ryoma_tanaka: COPD急性増悪に抗菌薬は有効か?というコクランレビュー。 ICU患者では明らかに有効という結果。この条件に合うRCTは1つしかないので、その1つの結果からなのですが。 https://t.co/xlM0T3ImcT
RT @ryoma_tanaka: COPD急性増悪に抗菌薬は有効か?というコクランレビュー。 ICU患者では明らかに有効という結果。この条件に合うRCTは1つしかないので、その1つの結果からなのですが。 https://t.co/xlM0T3ImcT
COPD急性増悪に抗菌薬は有効か?というコクランレビュー。 ICU患者では明らかに有効という結果。この条件に合うRCTは1つしかないので、その1つの結果からなのですが。 https://t.co/xlM0T3ImcT
Limited and inconsistent benefit of #antibiotics in #copd calls for more research to identify #biomarkers that can allow targeting. Often they receive repeated courses. How do we identify which patients need steroids only? #WAAW2018 https://t.co/GXKRF0i9X
RT @ladenheimd: More from @cochranecollab. A recent audit of GP practices @ENHertsCCG showed many pts in this cohort are on 12 or more acut…
RT @DrNuala: Do patients with acute exacerbation COPD benefit from antibiotics? ANS = probably not Current data are not conclusive Anti…
RT @DrNuala: Do patients with acute exacerbation COPD benefit from antibiotics? ANS = probably not Current data are not conclusive Anti…
More from @cochranecollab. A recent audit of GP practices @ENHertsCCG showed many pts in this cohort are on 12 or more acute treatment courses a year! Evidence to help update our local guidance. Many thanks @CochraneAirways . https://t.co/Am4u1YDH3u https:
RT @DrNuala: Do patients with acute exacerbation COPD benefit from antibiotics? ANS = probably not Current data are not conclusive Anti…
Do patients with acute exacerbation COPD benefit from antibiotics? ANS = probably not Current data are not conclusive Antibiotics can cause patient harm too use wisely and safely @gpbuddy #AntibioticResistance https://t.co/tip7yj16uE
RT @PuhanMilo: update of cochrane review on antibiotics for exacerbations of COPD out https://t.co/Mz3fT5LSrc
update of cochrane review on antibiotics for exacerbations of COPD out https://t.co/Mz3fT5LSrc
RT @CIDRAP_ASP: .@CochraneAirways published reviews on antibiotic use for acute COPD exacerbations (https://t.co/ldaxRDiViH) and COPD proph…
RT @CIDRAP_ASP: .@CochraneAirways published reviews on antibiotic use for acute COPD exacerbations (https://t.co/ldaxRDiViH) and COPD proph…
.@CochraneAirways published reviews on antibiotic use for acute COPD exacerbations (https://t.co/ldaxRDiViH) and COPD prophylactic therapy (https://t.co/ZfsRgFaXPm), highlighting the need to balance benefits and harms to individuals and populations